全文获取类型
收费全文 | 1268245篇 |
免费 | 94112篇 |
国内免费 | 1970篇 |
专业分类
耳鼻咽喉 | 18175篇 |
儿科学 | 42143篇 |
妇产科学 | 37805篇 |
基础医学 | 185624篇 |
口腔科学 | 35329篇 |
临床医学 | 107521篇 |
内科学 | 249451篇 |
皮肤病学 | 26453篇 |
神经病学 | 98503篇 |
特种医学 | 49950篇 |
外国民族医学 | 366篇 |
外科学 | 196986篇 |
综合类 | 26477篇 |
现状与发展 | 1篇 |
一般理论 | 300篇 |
预防医学 | 92019篇 |
眼科学 | 28953篇 |
药学 | 97511篇 |
1篇 | |
中国医学 | 2435篇 |
肿瘤学 | 68324篇 |
出版年
2018年 | 11807篇 |
2015年 | 11611篇 |
2014年 | 15995篇 |
2013年 | 24343篇 |
2012年 | 33540篇 |
2011年 | 35936篇 |
2010年 | 21205篇 |
2009年 | 20013篇 |
2008年 | 34973篇 |
2007年 | 37940篇 |
2006年 | 38497篇 |
2005年 | 37791篇 |
2004年 | 36369篇 |
2003年 | 35270篇 |
2002年 | 34843篇 |
2001年 | 58007篇 |
2000年 | 59420篇 |
1999年 | 50373篇 |
1998年 | 13473篇 |
1997年 | 12030篇 |
1996年 | 12284篇 |
1995年 | 12275篇 |
1994年 | 11704篇 |
1993年 | 10813篇 |
1992年 | 40933篇 |
1991年 | 40347篇 |
1990年 | 39862篇 |
1989年 | 38683篇 |
1988年 | 36084篇 |
1987年 | 35326篇 |
1986年 | 33698篇 |
1985年 | 32123篇 |
1984年 | 23895篇 |
1983年 | 20780篇 |
1982年 | 12322篇 |
1981年 | 10877篇 |
1980年 | 10150篇 |
1979年 | 22601篇 |
1978年 | 15832篇 |
1977年 | 13684篇 |
1976年 | 12932篇 |
1975年 | 14165篇 |
1974年 | 16659篇 |
1973年 | 16042篇 |
1972年 | 15306篇 |
1971年 | 14222篇 |
1970年 | 13202篇 |
1969年 | 12720篇 |
1968年 | 11969篇 |
1967年 | 10458篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
Huang Sicong He Xintong Doyle Tracy J. Zaccardelli Alessandra Marshall Allison A. Friedlander H. Maura Blaustein Rachel B. Smith Elisabeth A. Cui Jing Iannaccone Christine K. Mahmoud Taysir G. Weinblatt Michael E. Dellaripa Paul F. Shadick Nancy A. Sparks Jeffrey A. 《Clinical rheumatology》2020,39(4):1371-1372
Clinical Rheumatology - The publisher regrets that the two sections under the Results omitted inadvertently on the original published version of the above article. 相似文献
992.
Rusman Tamara John Marie-Luise B. van der Weijden Mignon A. C. Boden Bouke J. H. van der Bijl Carmella M. A. Bruijnen Stefan T. G. van der Laken Conny J. Nurmohamed Mike T. van der Horst-Bruinsma Irene E. 《Clinical rheumatology》2020,39(5):1521-1529
Clinical Rheumatology - The primary aim is to evaluate signs of inflammation on MRI of sacroiliac joints (SIJ)/spine in inflammatory back pain (IBP) patients suspected of nr-axSpA with high disease... 相似文献
993.
994.
Anna Weiss MD Olga Martínez-Sáez MD PhD Adrienne G. Waks MD Alison Laws MD MPH Monica McGrath BA Paolo Tarantino MD Leah Portnow MD Eric Winer MD María Rey MD Marta Tapia MD Aleix Prat MD PhD Ann H. Partridge MD MPH Sara M. Tolaney MD MPH Juan M. Cejalvo MD PhD Elizabeth A. Mittendorf MD PhD MHCM Tari A. King MD 《Cancer》2023,129(12):1836-1845
995.
D. R. Frei R. Beasley D. Campbell A. Forbes K. Leslie D. Mackle C. Martin A. Merry M. R. Moore P. S. Myles L. Ruawai-Hamilton T. G. Short P. J. Young 《Anaesthesia》2023,78(10):1272-1284
International recommendations encourage liberal administration of oxygen to patients having surgery under general anaesthesia, ostensibly to reduce surgical site infection. However, the optimal oxygen regimen to minimise postoperative complications and enhance recovery from surgery remains uncertain. The hospital operating theatre randomised oxygen (HOT-ROX) trial is a multicentre, patient- and assessor-blinded, parallel-group, randomised clinical trial designed to assess the effect of a restricted, standard care, or liberal peri-operative oxygen therapy regimen on days alive and at home after surgery in adults undergoing prolonged non-cardiac surgery under general anaesthesia. Here, we report the findings of the internal vanguard feasibility phase of the trial undertaken in four large metropolitan hospitals in Australia and New Zealand that included the first 210 patients of a planned overall 2640 trial sample, with eight pre-specified endpoints evaluating protocol implementation and safety. We screened a total of 956 participants between 1 September 2019 and 26 January 2021, with data from 210 participants included in the analysis. Median (IQR [range]) time-weighted average intra-operative FiO2 was 0.30 (0.26–0.35 [0.20–0.59]) and 0.47 (0.44–0.51 [0.37–0.68]) for restricted and standard care, respectively (mean difference (95%CI) 0.17 (0.14–0.20), p < 0.001). Median time-weighted average intra-operative FiO2 was 0.83 (0.80–0.85 [0.70–0.91]) for liberal oxygen therapy (mean difference (95%CI) compared with standard care 0.36 (0.33–0.39), p < 0.001). All feasibility endpoints were met. There were no significant patient adverse events. These data support the feasibility of proceeding with the HOT-ROX trial without major protocol modifications. 相似文献
996.
997.
Ian H. de Boer Charles E. Alpers Evren U. Azeloglu Ulysses G.J. Balis Jonathan M. Barasch Laura Barisoni Kristina N. Blank Andrew S. Bomback Keith Brown Pierre C. Dagher Ashveena L. Dighe Michael T. Eadon Tarek M. El-Achkar Joseph P. Gaut Nir Hacohen Yongqun He Jeffrey B. Hodgin Sanjay Jain Sandy Alfano 《Kidney international》2021,99(3):498-510
998.
Steven P. Rowe MD PhD Martin G. Pomper MD PhD 《CA: a cancer journal for clinicians》2022,72(4):333-352
The authors define molecular imaging, according to the Society of Nuclear Medicine and Molecular Imaging, as the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems. Although practiced for many years clinically in nuclear medicine, expansion to other imaging modalities began roughly 25 years ago and has accelerated since. That acceleration derives from the continual appearance of new and highly relevant animal models of human disease, increasingly sensitive imaging devices, high-throughput methods to discover and optimize affinity agents to key cellular targets, new ways to manipulate genetic material, and expanded use of cloud computing. Greater interest by scientists in allied fields, such as chemistry, biomedical engineering, and immunology, as well as increased attention by the pharmaceutical industry, have likewise contributed to the boom in activity in recent years. Whereas researchers and clinicians have applied molecular imaging to a variety of physiologic processes and disease states, here, the authors focus on oncology, arguably where it has made its greatest impact. The main purpose of imaging in oncology is early detection to enable interception if not prevention of full-blown disease, such as the appearance of metastases. Because biochemical changes occur before changes in anatomy, molecular imaging—particularly when combined with liquid biopsy for screening purposes—promises especially early localization of disease for optimum management. Here, the authors introduce the ways and indications in which molecular imaging can be undertaken, the tools used and under development, and near-term challenges and opportunities in oncology. 相似文献
999.
Biomedical Engineering - The possible use of the vortex effect in medical transfusion–infusion solution heaters was studied. A design for a device is presented, along with the trial results.... 相似文献